
|Articles|May 1, 2001
Postmenopausal estrogen therapy and ovarian cancer
Small patient numbers, weak associations, plus the mixed story in the observational studies complicate accurate interpretation of the latest epidemiologic study on ERT.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA initiates removal of boxed warnings, requests updated labeling for menopausal hormone therapy
2
Study reveals implantation and live birth rates for segmental aneuploid embryos
3
Sage Wyatt, PhD, discusses cardiovascular risk assessment through HDP
4
















